Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




ONTARGET MRI Study: No Benefit of Combination Therapy on Left Ventricular Mass
Link ID 6035
Title ONTARGET MRI Study: No Benefit of Combination Therapy on Left Ventricular Mass
Url http://www.medscape.com/viewarticle/575018?src=rss
Description A new ONTARGET imaging study has shown no difference between ramipril, telmisartan, or the combination in the reduction of left ventricular mass. The MRI study, say investigators, closely parallels the main findings from ONTARGET, showing no clear advantage to combination therapy. Heartwire
Category Articles > Cardiology
Keywords
Date May 24, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Many US Adults, Especially High-Risk Individuals, Not at Recommended Lipid Targets
  There remains a significant gap in overall lipid control, especially among individuals with cardiovascular comorbidities, say authors of a new study. Less than one in five high-risk individuals are meeting the recommended targets for all lipids, including LDL cholesterol, HDL cholesterol, and triglycerides. Heartwire
Category:   Articles > Cardiology


2. Pharmacist Web Support Helps Get to Blood-Pressure Goals
  Patients with hypertension who monitored their blood pressure from home and received Web-based pharmacist care showed greater improvement in blood pressure control than patients who had usual care. Medscape Medical News
Category:   Articles > Cardiology


3. Fragmented QRS: A Marker of Increased Cardiac Risk
  Fragmentation of the QRS complexes on a 12-lead ECG appears to be a significant marker for future cardiac events in patients with coronary heart disease, a new study shows. Heartwire
Category:   Articles > Cardiology


4. New Strategies Address Racial Disparities in Cardiovascular Care
  The Ex-STAND Study showed that amlodipine and valsartan were well tolerated and lowered blood pressure in blacks more effectively than did amlodipine monotherapy. Medscape Medical News
Category:   Articles > Cardiology


5. Thiazides First-Choice Antihypertensive Even for Patients With Metabolic Syndrome
  New findings from ALLHAT do not support a preference for calcium blockers, alpha blockers, or ACE inhibitors over thiazide diuretics in patients with the metabolic syndrome, despite their more favorable metabolic profiles. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS